MARÍA DE LAS MERCEDES MARÍN ARRIAZA-rekin lankidetzan egindako argitalpenak (43)

2023

  1. A mutation responsible for impaired detection by the Xpert SARS-CoV-2 assay independently emerged in different lineages during the SARS-CoV-2 pandemic

    BMC Microbiology, Vol. 23, Núm. 1

  2. Clinical impact of time to results from the microbiology laboratory in bloodstream infections caused by carbapenemase-producing Enterobacterales (TIME-CPE STUDY)

    The Journal of antimicrobial chemotherapy, Vol. 78, Núm. 8, pp. 1948-1954

  3. Contemporary use of cefazolin for MSSA infective endocarditis: analysis of a national prospective cohort

    International Journal of Infectious Diseases, Vol. 137, pp. 134-143

  4. Pneumocystis jirovecii Pneumonia Diagnostic Approach: Real-Life Experience in a Tertiary Centre

    Journal of Fungi, Vol. 9, Núm. 4

  5. Pneumocystis jirovecii pneumonia in intensive care units: a multicenter study by ESGCIP and EFISG

    Critical Care, Vol. 27, Núm. 1

  6. Real-world Use of Bezlotoxumab and Fecal Microbiota Transplantation for the Treatment of Clostridioides difficile Infection

    Open Forum Infectious Diseases, Vol. 10, Núm. 2

2022

  1. Abiotrophia spp. and Granulicatella spp. Infective Endocarditis: A Contemporary Perspective

    Frontiers in bioscience (Elite edition), Vol. 14, Núm. 3, pp. 23

  2. Different performance of three point-of-care SARS-CoV-2 antigen detection devices in symptomatic patients and close asymptomatic contacts: a real-life study

    Clinical Microbiology and Infection, Vol. 28, Núm. 6, pp. 865-870

  3. Infective endocarditis in children and adolescents: a different profile with clinical implications

    Pediatric Research, Vol. 92, Núm. 5, pp. 1400-1406

  4. Nosocomial Transmission of SARS-CoV-2 Involving Vaccinated Health Care Workers

    Microbiology Spectrum, Vol. 10, Núm. 1

  5. Outpatient Parenteral Antibiotic Treatment vs Hospitalization for Infective Endocarditis: Validation of the OPAT-GAMES Criteria

    Open Forum Infectious Diseases, Vol. 9, Núm. 9

2021

  1. Clinical Features and Outcomes of Streptococcus anginosus Group Infective Endocarditis: A Multicenter Matched Cohort Study

    Open Forum Infectious Diseases, Vol. 8, Núm. 6

  2. Inference of active viral replication in cases with sustained positive reverse transcription-PCR results for SARS-CoV-2

    Journal of Clinical Microbiology, Vol. 59, Núm. 2

  3. Invasive pulmonary aspergillosis in the COVID-19 era: An expected new entity

    Mycoses, Vol. 64, Núm. 2, pp. 132-143

  4. Mural Endocarditis: The GAMES Registry Series and Review of the Literature

    Infectious Diseases and Therapy, Vol. 10, Núm. 4, pp. 2749-2764

  5. Prevalence of Colorectal Neoplasms Among Patients With Enterococcus faecalis Endocarditis in the GAMES Cohort (2008–2017)

    Mayo Clinic Proceedings, Vol. 96, Núm. 1, pp. 132-146

2020

  1. A Contemporary Picture of Enterococcal Endocarditis

    Journal of the American College of Cardiology, Vol. 75, Núm. 5, pp. 482-494

  2. Clinical impact of a Clostridioides (Clostridium) difficile bedside infectious disease stewardship intervention

    JAC-Antimicrobial Resistance, Vol. 2, Núm. 3

  3. Faecal microbiota transplantation for recurrent Clostridioides difficile infection: experience with lyophilized oral capsules

    Journal of Hospital Infection, Vol. 105, Núm. 2, pp. 319-324

  4. Three different patterns of positive Clostridium difficile laboratory tests. A comparison of clinical behavior

    Diagnostic Microbiology and Infectious Disease, Vol. 97, Núm. 3